Paula H. Cholmondeley - 02 Nov 2023 Form 3 Insider Report for Lexeo Therapeutics, Inc. (LXEO)

Role
Director
Signature
/s/ Jenny Robertson, Attorney-in-Fact
Issuer symbol
LXEO
Transactions as of
02 Nov 2023
Net transactions value
$0
Form type
3
Filing time
02 Nov 2023, 21:17:51 UTC
Previous filing
08 Nov 2022
Next filing
27 Jun 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding LXEO Common Stock 15,627 02 Nov 2023 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding LXEO Stock Option (right to buy) 02 Nov 2023 Common Stock 44,184 $11.02 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 1/48th of the shares vested or vest in monthly installments commencing on December 1, 2021, subject to the Reporting Person's continuous service.
F2 1/48th of the shares underlying the option shall vest in monthly installments commencing on September 22, 2023, subject to the Reporting Person's continuous service.

Remarks:

Exhibit List - Exhibit 24 - Power of Attorney